Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3555)
MapLight Therapeutics, Inc. (MLPT)
Catalyst4, Inc. — 10% Owner
Shares
1,000,000
Price
$13.00
Total Value
$13.00M
Shares Held After
20,906,689
% of Holdings
4.8%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
3,847
Price
$23.38
Total Value
$89.95K
Shares Held After
121,338
% of Holdings
3.1%
Nurix Therapeutics, Inc. (NRIX)
van Houte Hans — Chief Financial Officer
Shares
2,845
Price
$23.38
Total Value
$66.52K
Shares Held After
44,927
% of Holdings
6.0%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
3,847
Price
$23.38
Total Value
$89.95K
Shares Held After
19,912
% of Holdings
16.2%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
14,000
Price
$79.88
Total Value
$1.12M
Shares Held After
58,555
% of Holdings
19.3%
PROTHENA CORP PUBLIC LTD CO (PRTA)
Isaacs Michael John — General Counsel&Company Sec.
Shares
8,386
Price
$8.47
Total Value
$71.06K
Shares Held After
35,745
% of Holdings
19.0%
PROTHENA CORP PUBLIC LTD CO (PRTA)
Kingston Anne Evans — Chief Strategy Officer
Shares
7,662
Price
$8.47
Total Value
$64.92K
Shares Held After
55,782
% of Holdings
12.1%
MapLight Therapeutics, Inc. (MLPT)
Catalyst4, Inc. — 10% Owner
Shares
3,000
Price
$12.63
Total Value
$37.89K
Shares Held After
19,906,689
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,240
Price
$525.46
Total Value
$651.57K
Shares Held After
324,443
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,982
Price
$524.47
Total Value
$1.04M
Shares Held After
325,683
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,318
Price
$523.62
Total Value
$690.14K
Shares Held After
327,665
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
880
Price
$522.51
Total Value
$459.81K
Shares Held After
328,983
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,270
Price
$521.32
Total Value
$662.08K
Shares Held After
329,863
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
900
Price
$520.40
Total Value
$468.36K
Shares Held After
331,133
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,112
Price
$519.29
Total Value
$577.45K
Shares Held After
332,033
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
798
Price
$518.25
Total Value
$413.56K
Shares Held After
333,145
% of Holdings
0.2%
Greenwich LifeSciences, Inc. (GLSI)
Patel Snehal — Director
Shares
700
Price
$13.10
Total Value
$9.17K
Shares Held After
5,611,402
% of Holdings
0.0%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
5,000
Price
$0.78
Total Value
$3.90K
Shares Held After
373,885
% of Holdings
1.3%
Viking Therapeutics, Inc. (VKTX)
Mancini Marianna — Chief Operating Officer
Shares
18,217
Price
$33.47
Total Value
$609.64K
Shares Held After
422,760
% of Holdings
4.1%
Viking Therapeutics, Inc. (VKTX)
Lian Brian — Director
Shares
148,517
Price
$33.32
Total Value
$4.95M
Shares Held After
2,572,441
% of Holdings
5.5%
Viking Therapeutics, Inc. (VKTX)
ZANTE GREG — Chief Financial Officer
Shares
21,217
Price
$33.47
Total Value
$710.14K
Shares Held After
212,204
% of Holdings
9.1%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
1,600
Price
$5.00
Total Value
$8.00K
Shares Held After
393,266
% of Holdings
0.4%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
1,810
Price
$5.00
Total Value
$9.05K
Shares Held After
391,666
% of Holdings
0.5%
Outlook Therapeutics, Inc. (OTLK)
Sukhtian Faisal Ghiath — Director
Shares
95,398
Price
$1.05
Total Value
$100.00K
Shares Held After
220,972
% of Holdings
43.2%
MapLight Therapeutics, Inc. (MLPT)
Catalyst4, Inc. — 10% Owner
Shares
65,137
Price
$11.69
Total Value
$761.39K
Shares Held After
19,903,689
% of Holdings
0.3%
MapLight Therapeutics, Inc. (MLPT)
Catalyst4, Inc. — 10% Owner
Shares
141,088
Price
$10.74
Total Value
$1.52M
Shares Held After
19,838,552
% of Holdings
0.7%
Relay Therapeutics, Inc. (RLAY)
Rahmer Peter — Cheif Corporate Development Officer
Shares
748
Price
$18.61
Total Value
$13.92K
Shares Held After
228,165
% of Holdings
0.3%
Karyopharm Therapeutics Inc. (KPTI)
Poulton Stuart — EVP, Chief Development Officer
Shares
189
Price
$7.10
Total Value
$1.34K
Shares Held After
94,632
% of Holdings
0.2%
Relay Therapeutics, Inc. (RLAY)
Bergstrom Donald A — President, R&D
Shares
2,237
Price
$18.61
Total Value
$41.63K
Shares Held After
407,660
% of Holdings
0.5%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
1,459
Price
$18.61
Total Value
$27.15K
Shares Held After
158,285
% of Holdings
0.9%
Greenwich LifeSciences, Inc. (GLSI)
Patel Snehal — Director
Shares
1,500
Price
$13.59
Total Value
$20.39K
Shares Held After
5,610,702
% of Holdings
0.0%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
6,400
Price
$4.95
Total Value
$31.68K
Shares Held After
389,856
% of Holdings
1.6%
Editas Medicine, Inc. (EDIT)
Burkly Linda — EVP, CHIEF SCIENTIFIC OFFICER
Shares
4,928
Price
$2.67
Total Value
$13.16K
Shares Held After
62,369
% of Holdings
7.3%
MapLight Therapeutics, Inc. (MLPT)
Cox Troy — Director
Shares
15,620
Price
$9.52
Total Value
$148.70K
Shares Held After
15,620
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$532.49
Total Value
$21.30K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
403
Price
$530.97
Total Value
$213.98K
Shares Held After
324,483
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,124
Price
$530.29
Total Value
$596.05K
Shares Held After
324,886
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
625
Price
$529.41
Total Value
$330.88K
Shares Held After
326,010
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,149
Price
$528.20
Total Value
$606.90K
Shares Held After
326,635
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,369
Price
$527.16
Total Value
$721.68K
Shares Held After
327,784
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,473
Price
$526.34
Total Value
$775.29K
Shares Held After
329,153
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
876
Price
$525.02
Total Value
$459.92K
Shares Held After
330,626
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,074
Price
$524.04
Total Value
$562.82K
Shares Held After
331,502
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,367
Price
$523.15
Total Value
$715.15K
Shares Held After
332,576
% of Holdings
0.4%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President&Immunovant CEO
Shares
200,000
Price
$34.95
Total Value
$6.99M
Shares Held After
1,613,063
% of Holdings
11.0%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
7,798
Price
$5.00
Total Value
$38.99K
Shares Held After
383,456
% of Holdings
2.0%
Liquidia Corp (LQDA)
Adair Jason — Chief Business Officer
Shares
688
Price
$87.53
Total Value
$60.22K
Shares Held After
216,438
% of Holdings
0.3%
Beam Therapeutics Inc. (BEAM)
Simon Amy — Chief Medical Officer
Shares
16,667
Price
$25.74
Total Value
$429.04K
Shares Held After
85,696
% of Holdings
16.3%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
1,000
Price
$20.00
Total Value
$20.00K
Shares Held After
51,776
% of Holdings
1.9%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
7
Price
$42.73
Total Value
$299.14
Shares Held After
537,607
% of Holdings
0.0%
Showing 1–50 of 3555 transactions (page 1 of 72)